Lankford, Colleagues Demand FTC Finish Investigation Of Prescription Drug Price Middlemen
October 07, 2022
October 07, 2022
OKLAHOMA CITY, Oklahoma, Oct. 7 -- Sen. James Lankford, R-Oklahoma, issued the following news release on Oct. 7, 2022, and letter:
Senator James Lankford (R-OK), a member of the Senate Finance Committee, joined his colleagues to send a letter to Federal Trade Commission (FTC) Chair Lina Khan to ask the FTC to complete its pharmacy benefit manager (PBM) investigation in a timely manner. Lankford sent a letter to the FTC in June to encourage this ongoing investigation into the practic . . .
Senator James Lankford (R-OK), a member of the Senate Finance Committee, joined his colleagues to send a letter to Federal Trade Commission (FTC) Chair Lina Khan to ask the FTC to complete its pharmacy benefit manager (PBM) investigation in a timely manner. Lankford sent a letter to the FTC in June to encourage this ongoing investigation into the practic . . .